prev next front |1 |2 |3 |4 |5 |6 |7 |8 |9 |10 |11 |12 |13 |14 |15 |16 |17 |18 |19 |20 |21 |22 |23 |24 |25 |26 |27 |28 |29 |30 |31 |32 |33 |34 |35 |review

Doctor ‘A’ believes the new treatment (chemoRT) is more worthwhile than RT alone if:

at least an extra 5 out of his next 100 patients will be cured due to the new treatment
AND
at most an extra 50 of these 100 patients will experience G3/4 toxicity due to the new treatment

How confident can Doctor ‘A’ be that this scenario is supported by the Intergroup study?